Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples